Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:INNO)

Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain

Canada NewsWire 11 days ago

Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

Canada NewsWire April 1, 2024

Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.

Canada NewsWire March 25, 2024

Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million

Canada NewsWire March 14, 2024

Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study

Canada NewsWire March 5, 2024

Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits

Canada NewsWire February 26, 2024

Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024

Canada NewsWire February 20, 2024

Innocan Pharma to provide a corporate update via Zoom livestream on February 12, 2024, at 4:00pm EST

Canada NewsWire February 5, 2024

Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration

Canada NewsWire December 12, 2023
View More News ››

Opinion & Analysis (CSE:INNO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (CSE:INNO)

Innocan Pharma Reports Q2 2023 Results

US$3.121M Revenues for Q2, 2023 compared to US$415,000 for Q2 2022, representing an increase of 652% US$2.656M...
Betteryear2 - August 25, 2023

RE: Private Placement of Units at a 9% Prime Above Share Price

Note: There appears to be an error in release. It states: The Offering is expected to close on or around July 20, 2023. The...
Betteryear2 - July 25, 2023

Private Placement of Units at a 9% Prime Above Share Price

HERZLIYA, Israel, and CALGARY, Alberta, July 25, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE:...
Betteryear2 - July 25, 2023

Innocan Pharma's Compassionate Care Treatment for Dogs

A Case Report Published in Frontiers in Veterinary Science Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 29, 2022) -...
Betteryear2 - April 29, 2022

Innocan Pharma's Case Report Accepted

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - April 11, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB...
Betteryear2 - April 11, 2022

Inauguration of Its Drug Development Lab

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - January 17, 2022) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB...
Betteryear2 - January 17, 2022
View more Bullboard ››

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria and an ...
View More »